For RA, about 10 biological agents are currently available by targeting specific molecules involved in the disease mechanisms of chronic synovitis at different molecular target (ie, ligand, receptor), inflammatory cytokine cascade (ie, IL1‐β, TNF‐α, and IL‐6), and cell type (ie, B cell, T cell). The gene discussed is TNF; the disease is rheumatoid arthritis.